Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Liabilities and Shareholders Equity (2016 - 2026)

Cryo Cell International's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $60.9 million for Q1 2026.

  • Quarterly results put Liabilities and Shareholders Equity at $60.9 million for Q1 2026, down 5.43% from a year ago — trailing twelve months through Feb 2026 was $250.2 million (down 1.7% YoY), and the annual figure for FY2025 was $61.7 million, down 4.56%.
  • Liabilities and Shareholders Equity for Q1 2026 was $60.9 million at Cryo Cell International, down from $61.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $69.8 million in Q3 2023 to a low of $54.8 million in Q1 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $64.4 million (2025), against an average of $63.4 million.
  • Peak annual rise in Liabilities and Shareholders Equity hit 440.93% in 2022, while the deepest fall reached 47.93% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $64.9 million in 2022, then decreased by 0.32% to $64.7 million in 2023, then changed by 0.0% to $64.7 million in 2024, then dropped by 4.56% to $61.7 million in 2025, then fell by 1.37% to $60.9 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $60.9 million, $61.7 million, and $63.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.